pf 5901 has been researched along with baicalein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruneau, P; Delvare, C; Edwards, MP; McMillan, RM | 1 |
Adrian, TE; Ding, XZ; El-Metwally, TH; Kuszynski, CA | 1 |
2 other study(ies) available for pf 5901 and baicalein
Article | Year |
---|---|
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
Topics: Administration, Oral; Animals; Chemical Phenomena; Chemistry; Dinoprostone; Dogs; Humans; Indazoles; Leukotriene B4; Lipoxygenase Inhibitors; Male; Methemoglobinemia; Methylation; Molecular Structure; Oxidation-Reduction; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship; Thromboxane B2 | 1991 |
Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Topics: Apoptosis; Carbonic Anhydrases; Cell Differentiation; Cell Division; Cell Size; DNA Fragmentation; Flavanones; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Lipoxygenase Inhibitors; Masoprocol; Pancreatic Neoplasms; Propidium; Quinolines; Tumor Cells, Cultured | 1999 |